According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is $7.63. In 2022 the company made an earnings per share (EPS) of $19.91 an increase over its 2021 EPS that were of -$34.42.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $6.85 | -65.62% |
2022 | $19.91 | -157.83% |
2021 | -$34.42 | -35.22% |
2020 | -$53.14 | -5.63% |
2019 | -$56.32 | 20.34% |
2018 | -$46.80 | 55.26% |
2017 | -$30.14 | -19.15% |
2016 | -$37.28 | -6% |
2015 | -$39.66 | 42.86% |
2014 | -$27.76 | 52.17% |
2013 | -$18.24 | -41.03% |
2012 | -$30.93 | -93.62% |
2011 | -$485.08 | -65.57% |
2010 | -$1,409 | 88.66% |
2009 | -$746.77 | -32.78% |
2008 | -$1,111 | 16.59% |
2007 | -$952.88 | 26.96% |
2006 | -$750.54 | -11743.27% |
2005 | $6.45 | -101.88% |
2004 | -$342.70 | -554.77% |
2003 | $75.36 | 216.55% |
2002 | $23.81 | -85.01% |
2001 | $158.82 | 369.94% |
2000 | $33.79 | 404.51% |
1999 | $6.70 |